November 3, 2014

The RAND Corp. projected that the introduction of biosimilar drugs in the United States will reduce direct spending on biologics by $44.2 billion from 2014 to 2024.


October 31, 2014

Mylan on Friday announced the launch of nevirapine extended-release tablets in 400-mg strength, a generic version of Viramune XR from Boehringer Ingelheim. 

October 30, 2014

Sandoz, through its branded dermatology business PharmaDerm, and Medigene AG on Thursday announced a promotion agreement with Women's Choice Pharmaceuticals for Veregen (sinecatechins) ointment, 15% strength. 

October 29, 2014

The majority of independent community pharmacists are interested in incorporating personalized medicine services into their practices, but they require further education before this is possible.

October 28, 2014

he Food and Drug Administration last week announced approval for Obizur for the treatment of bleeding episodes in adults with acquired hemophilia A. 

October 28, 2014

From Oct. 27 through Nov. 1, 2014, more than 11,000 McKesson employees at more than 170 locations across the United States will participate in the 16th Community Days program.

October 28, 2014

Onco360, one of the nation’s largest independent providers of oncology pharmacy services, on Monday announced that Paul Jardina was named president and CEO.

October 27, 2014

Burmans, an independent community pharmacy, was announced as a winner of the Patient Safety Award at the annual Innovation Awards presented by Philadelphia Business Journal and UnitedHealthcare.

October 24, 2014

In the wake of an Oct. 21 blogpost on Health Affairs, “The $500 Billion Medicare Slowdown: A Story About Part D,” Ralph Neas, president and CEO of the Generic Pharmacuetical Association, issued the following statement.

October 24, 2014

Pfizer on Thursday announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules.

October 23, 2014

The Center for Healthcare Supply Chain Research and the American Association of Colleges of Pharmacy are partnering to provide the nation’s schools of pharmacy a supply chain educational tool surrounding the distribution of specialty pharmaceuticals. 

October 22, 2014

The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.


October 21, 2014

Boehringer Ingelheim Pharmaceuticals on Monday announced that Ofev (nintedanib) capsules are now available in the United States. Ofev was approved by the Food and Drug Administration on Oct. 15 to treat idiopathic pulmonary fibrosis.

October 21, 2014

McKesson and Health Mart on Monday featured solutions designed to help community pharmacies deliver better patient care and sustain growth.


October 20, 2014

Cardinal Health on Monday announced that independent pharmacies can now take advantage of opportunities to co-brand with the Medicine Shoppe and Medicap Pharmacy franchising systems.

October 17, 2014

A new study published Thursday by the Center for Healthcare Supply Chain Research identifies factors, based on an analysis of European models, that may affect the American launch of biosimilars and their marketplace potential in the United States.

October 16, 2014

Specialty pharmacy Burmans last week received the new “Shaping Healthcare Delivery” award at this year’s AmerisourceBergen’s ThinkLive Conference. 

October 10, 2014

The Ohio State University, Cardinal Health and State of Ohio Third Frontier Commission on Wednesday announced the completion of a new, $13 million molecular imaging pharmaceuticals center.

October 10, 2014

Shares of Diplomat Pharmacy officially began trading on Friday at a price that had reached more than $17 per share in mid-afternoon trading.


October 9, 2014

Catamaran, a provider of technology and pharmacy benefit management services, on Wednesday announced that it has entered into a definitive agreement to acquire Salveo Specialty Pharmacy.

October 8, 2014

The Pharmaceutical Research and Manufacturers of America on Tuesday released a new report highlighting the number of investigational cancer medicines that did not succeed in clinical trials. 

October 8, 2014

Boehringer Ingelheim on Wednesday announced that its Striverdi Respimat (olodaterol) inhalation spray in 5-mcg dosage strength is now available by prescription in pharmacies across the United States. 

October 7, 2014

Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.

October 7, 2014

America’s biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new PhRMA report.